There will be no more faculty surveys at MD Anderson, UT System Chancellor William McRaven pledged to the institution's faculty in a closed-door meeting March 18.
A new study found that capping the cost-sharing for prescription drugs on individual policies in the health insurance marketplace would reduce patients' annual out-of-pocket healthcare spending, and have a small effect on insurance premiums while allowing insurers to remain compliant with the law.
FDA granted Orphan Drug Designation for Reolysin for the treatment of cancer of the fallopian tube.
FDA granted Fast Track Designation for HS-410 (vesigenurtacel-L) for the treatment of non-muscle invasive bladder cancer.
FDA approved Unituxin (dinutuximab) as part of first-line therapy for pediatric patients with high-risk neuroblastoma.
A group of cancer researchers, in collaboration with Apple Inc. and Sage Bionetworks, launched a mobile app that breast cancer patients track their symptoms and progress.
NANCY DAVIDSON was named president-elect of the American Association for Cancer Research. She will officially take the position at the AACR's Annual Meeting, being held April 18-22 in Philadelphia, and will assume the presidency in April 2016.
VARIAN MEDICAL SYSTEMS was selected to equip and service two new national proton therapy centers in England with the Varian ProBeam proton therapy system. Under a public tender, Varian was selected as the preferred supplier to provide equipment and service to operate two three-room centers to be constructed in London and Manchester in a contract valued at up to £80 million.
THE WORLD MOLECULAR IMAGING SOCIETY will collaborate with NCI to promote best practices for co-clinical trials.
New hepatitis C therapies with high price tags and the exploitation of loopholes for compounded medications contributed to a 13.1 percent increase in U.S. drug spending in 2014, a rate not seen in more than a decade, according to the 2014 Express Scripts Drug Trend Report.
